• Je něco špatně v tomto záznamu ?

Acute portal vein thrombosis in noncirrhotic patients - different prognoses based on presence of inflammatory markers: a long-term multicenter retrospective analysis

R. Keil, J. Koželuhová, J. Dolina, A. Hep, R. Kroupa, V. Kojecký, T. Krejčí, J. Havlín, I. Hadačová, J. Segethová, P. Koptová, Z. Zádorová, J. Matouš, B. Frýbová, P. Chmátal, M. Wasserbauer, J. Šťovíček, M. Bae, T. Guven, M. Zaeem, Š. Hlava,

. 2019 ; 54 (11) : 1379-1384. [pub] 20191019

Jazyk angličtina Země Velká Británie

Typ dokumentu srovnávací studie, časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc20025560

Background: Portal vein thrombosis (PVT) is a partial or complete thrombotic occlusion of the portal vein and is rare in noncirrhotic patients.Patients and methods: 78 adult patients with noncirrhotic acute PVT without known malignity were evaluated. Patients with initial CRP level 61-149 mg/l were excluded.Results: Patients were divided into two groups - the first one (33 patients) was characterized with signs of inflammation and CRP over 149 mg/l. The second group (45 patients) was without signs of inflammation and CRP level less than 61 mg/l. The frequency of prothrombotic hematologic factors was statistically significantly different in levels of factor VIII and MTHFR 677 C mutation. All patients from both groups underwent the same oncologic and hemato-oncologic screening which was positive in 23 patients (51.1%) in the group without signs of inflammation. In the group of patients with clinical and laboratory signs of inflammation oncologic and hemato-oncologic screening was positive only in 1 patient (3.0%). Complete portal vein recanalization was achieved in 19.2%, partial recanalization in 26.9%.Conclusions: Patients with clinical signs of inflammation and acute PVT have a low risk of malignancy in contrast to patients without signs of inflammation and acute PVT, which have a high risk of oncologic or hemato-oncologic disease. Patients with negative hemato-oncologic screening should be carefully observed over time because we expect they are at higher risk for the development of hemato-oncologic disease, independent from the presence and number of procoagulation risk factors.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025560
003      
CZ-PrNML
005      
20230614130716.0
007      
ta
008      
201125s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/00365521.2019.1677768 $2 doi
035    __
$a (PubMed)31630579
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Keil, Radan $u Department of Internal Medicine, Motol University Hospital, Prague, Czech Republic.
245    10
$a Acute portal vein thrombosis in noncirrhotic patients - different prognoses based on presence of inflammatory markers: a long-term multicenter retrospective analysis / $c R. Keil, J. Koželuhová, J. Dolina, A. Hep, R. Kroupa, V. Kojecký, T. Krejčí, J. Havlín, I. Hadačová, J. Segethová, P. Koptová, Z. Zádorová, J. Matouš, B. Frýbová, P. Chmátal, M. Wasserbauer, J. Šťovíček, M. Bae, T. Guven, M. Zaeem, Š. Hlava,
520    9_
$a Background: Portal vein thrombosis (PVT) is a partial or complete thrombotic occlusion of the portal vein and is rare in noncirrhotic patients.Patients and methods: 78 adult patients with noncirrhotic acute PVT without known malignity were evaluated. Patients with initial CRP level 61-149 mg/l were excluded.Results: Patients were divided into two groups - the first one (33 patients) was characterized with signs of inflammation and CRP over 149 mg/l. The second group (45 patients) was without signs of inflammation and CRP level less than 61 mg/l. The frequency of prothrombotic hematologic factors was statistically significantly different in levels of factor VIII and MTHFR 677 C mutation. All patients from both groups underwent the same oncologic and hemato-oncologic screening which was positive in 23 patients (51.1%) in the group without signs of inflammation. In the group of patients with clinical and laboratory signs of inflammation oncologic and hemato-oncologic screening was positive only in 1 patient (3.0%). Complete portal vein recanalization was achieved in 19.2%, partial recanalization in 26.9%.Conclusions: Patients with clinical signs of inflammation and acute PVT have a low risk of malignancy in contrast to patients without signs of inflammation and acute PVT, which have a high risk of oncologic or hemato-oncologic disease. Patients with negative hemato-oncologic screening should be carefully observed over time because we expect they are at higher risk for the development of hemato-oncologic disease, independent from the presence and number of procoagulation risk factors.
650    _2
$a akutní nemoc $7 D000208
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a C-reaktivní protein $x analýza $7 D002097
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a zánět $x krev $7 D007249
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a vena portae $7 D011169
650    _2
$a prognóza $7 D011379
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a časové faktory $7 D013997
650    _2
$a žilní trombóza $x krev $x diagnóza $7 D020246
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Koželuhová, Jana $u Department of 1st Internal Medicine, University Hospital Pilsen, Pilsen, Czech Republic.
700    1_
$a Dolina, Jiří $u Department of Internal Medicine, University Hospital in Brno, Brno, Czech Republic.
700    1_
$a Hep, Aleš, $u Department of Internal Medicine, University Hospital in Brno, Brno, Czech Republic. $d 1952-2022 $7 mzk2003169597
700    1_
$a Kroupa, Radek $u Department of Internal Medicine, University Hospital in Brno, Brno, Czech Republic.
700    1_
$a Kojecký, Vladimír $u Department of Internal Medicine, Tomas Bata Regional Hospital in Zlin, Czech Republic.
700    1_
$a Krejčí, Tomáš $u Department of Surgery, Motol University Hospital, Prague, Czech Republic.
700    1_
$a Havlín, Jan $u 3rd Department of Surgery, Motol University Hospital, Prague, Czech Republic.
700    1_
$a Hadačová, Ivana $u Department of Hematology, Motol University Hospital, Prague, Czech Republic.
700    1_
$a Segethová, Jitka $u Department of Hematology, Motol University Hospital, Prague, Czech Republic.
700    1_
$a Koptová, Petra $u Department of Internal Medicine, Motol University Hospital, Prague, Czech Republic.
700    1_
$a Zádorová, Zdena $u 2nd Department of Internal Medicine, 3rd Faculty of Medicine, Charles University in Prague, University Hospital Královské Vinohrady, Czech Republic.
700    1_
$a Matouš, Jan $u 2nd Department of Internal Medicine, 3rd Faculty of Medicine, Charles University in Prague, University Hospital Královské Vinohrady, Czech Republic.
700    1_
$a Frýbová, Barbora $u Departement of Pediatric Surgery, University Hospital Motol, Prague, Czech Republic.
700    1_
$a Chmátal, Petr $u Department of Internal Medicine, Motol University Hospital, Prague, Czech Republic.
700    1_
$a Wasserbauer, Martin, $u Department of Internal Medicine, Motol University Hospital, Prague, Czech Republic. $d 1987- $7 xx0302700
700    1_
$a Šťovíček, Jan $u Department of Internal Medicine, Motol University Hospital, Prague, Czech Republic.
700    1_
$a Bae, Melvin $u Department of Internal Medicine, Motol University Hospital, Prague, Czech Republic.
700    1_
$a Guven, Tolga $u Department of Internal Medicine, Motol University Hospital, Prague, Czech Republic.
700    1_
$a Zaeem, Mahmood $u Department of Internal Medicine, Motol University Hospital, Prague, Czech Republic.
700    1_
$a Hlava, Štěpán $u Department of Internal Medicine, Motol University Hospital, Prague, Czech Republic.
773    0_
$w MED00010598 $t Scandinavian journal of gastroenterology $x 1502-7708 $g Roč. 54, č. 11 (2019), s. 1379-1384
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31630579 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20230614130712 $b ABA008
999    __
$a ok $b bmc $g 1599705 $s 1116246
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 54 $c 11 $d 1379-1384 $e 20191019 $i 1502-7708 $m Scandinavian journal of gastroenterology $n Scand J Gastroenterol $x MED00010598
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace